Guía práctica para el manejo de las espondiloartritis (ESPOGUIA): metodología y datos generales del documento

Akkoc, 2006, Ankylosing spondylitis and the spondyloarthropathies, 117 Zochling, 2006, ASAS/EULAR recommendations for the management of ankylosing spondylitis, Ann Rheum Dis, 65, 442, 10.1136/ard.2005.041137 Sidiropoulos, 2008, Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists, Rheumatology (Oxford), 47, 355, 10.1093/rheumatology/kem348 2005, Panel de expertos de la Sociedad Española de Reumatología (SER) Primer documento de consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNF alfa en las espondiloartritis, Reumatol Clin, 1, 32, 10.1016/S1699-258X(05)72710-8 Pham, 2006, TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology, Joint Bone Spine, 73, 547, 10.1016/j.jbspin.2006.02.005 Keat, 2005, BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology, Rheumatology (Oxford), 44, 939, 10.1093/rheumatology/keh669 Maksymowych, 2007, The Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project, J Rheumatol, 34, 2273 EBM Tools. Finding the Evidence. Levels of Evidence. Oxford: University of Oxford. Centre for Evidence-Based Medicine; 2001 [citado 15 Feb 2009]. Disponible en: http://www.cebm.net/index.aspx?o=1025